Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 958

1.

Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis.

Dazzan P, Lappin JM, Heslin M, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Doody GA, Morgan C.

Psychol Med. 2019 Jul 31:1-11. doi: 10.1017/S0033291719001399. [Epub ahead of print]

PMID:
31364523
2.

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.

Ferraro L, La Cascia C, Quattrone D, Sideli L, Matranga D, Capuccio V, Tripoli G, Gayer-Anderson C, Morgan C, Sami MB, Sham P, de Haan L, Velthorst E, Jongsma HE, Kirkbride JB, Rutten BPF, Richards AL, Roldan L, Arango C, Bernardo M, Bobes J, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Tortelli A, Szöke A, Del-Ben CM, Selten JP, Lynskey M, Jones PB, Van Os J, La Barbera D; WP2 EU-GEI GROUP , Murray RM, Di Forti M.

Schizophr Bull. 2019 Jul 29. pii: sbz077. doi: 10.1093/schbul/sbz077. [Epub ahead of print]

PMID:
31361020
3.

Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study.

Gaughran F, Stahl D, Stringer D, Hopkins D, Atakan Z, Greenwood K, Patel A, Smith S, Gardner-Sood P, Lally J, Heslin M, Stubbs B, Bonaccorso S, Kolliakou A, Howes O, Taylor D, Forti MD, David AS, Murray RM, Ismail K; IMPACT team.

Br J Psychiatry. 2019 Jul 26:1-8. doi: 10.1192/bjp.2019.159. [Epub ahead of print]

PMID:
31347480
4.

Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study.

Misra S, Gelaye B, Koenen KC, Williams DR, Borba CPC, Quattrone D, Di Forti M, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB; EU-GEI WP2 Group, Rutten BPF, van Os J, Murray RM, Gayer-Anderson C, Morgan C.

J Clin Med. 2019 Jul 23;8(7). pii: E1081. doi: 10.3390/jcm8071081.

5.

A method for cost-effective and rapid characterization of engineered T7-Based transcription factors by cell-free protein synthesis reveals insights into the regulation of T7 Rna polymerase-driven expression.

McManus JB, Lux MW, Murray RM, Emanuel PA.

Arch Biochem Biophys. 2019 Jul 18. pii: S0003-9861(19)30288-7. doi: 10.1016/j.abb.2019.07.010. [Epub ahead of print]

6.

Hard Limits and Performance Tradeoffs in a Class of Antithetic Integral Feedback Networks.

Olsman N, Baetica AA, Xiao F, Leong YP, Murray RM, Doyle JC.

Cell Syst. 2019 Jul 24;9(1):49-63.e16. doi: 10.1016/j.cels.2019.06.001. Epub 2019 Jul 3.

PMID:
31279505
7.

IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.

Ferraro L, Murray RM, Di Forti M, Quattrone D, Tripoli G, Sideli L, La Barbera D, La Cascia C.

Schizophr Res. 2019 Aug;210:81-88. doi: 10.1016/j.schres.2019.06.004. Epub 2019 Jul 2.

PMID:
31272907
8.

Should the supply of cannabis be legalised now?

Meacher M, Nutt D, Liebling J, Murray RM, Gridley A.

BMJ. 2019 Jul 3;366:l4473. doi: 10.1136/bmj.l4468. No abstract available.

PMID:
31270061
9.

Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.

Zanelli J, Mollon J, Sandin S, Morgan C, Dazzan P, Pilecka I, Reis Marques T, David AS, Morgan K, Fearon P, Doody GA, Jones PB, Murray RM, Reichenberg A.

Am J Psychiatry. 2019 Jul 1:appiajp201918091088. doi: 10.1176/appi.ajp.2019.18091088. [Epub ahead of print]

PMID:
31256609
10.

Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition.

Siriyong T, Murray RM, Bidgood LE, Young SA, Wright F, Parcell BJ, Voravuthikunchai SP, Coote PJ.

Sci Rep. 2019 Jun 24;9(1):9098. doi: 10.1038/s41598-019-45550-z.

11.

Corrigendum to "Dysconnectivity of neurocognitive networks at rest in very-preterm born adults" [NeuroImage: Clinical 4 (2014) 352-365].

White T, Symington I, Castellanos NP, Brittain PJ, Walsh SF, Nam KW, Sato JR, Allin MPG, Shergill SS, Murray RM, Williams SCR, Nosarti C.

Neuroimage Clin. 2019 Jun 20:101901. doi: 10.1016/j.nicl.2019.101901. [Epub ahead of print] No abstract available.

12.

The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.

Richards AL, Pardiñas AF, Frizzati A, Tansey KE, Lynham AJ, Holmans P, Legge SE, Savage JE, Agartz I, Andreassen OA, Blokland GAM, Corvin A, Cosgrove D, Degenhardt F, Djurovic S, Espeseth T, Ferraro L, Gayer-Anderson C, Giegling I, van Haren NE, Hartmann AM, Hubert JJ, Jönsson EG, Konte B, Lennertz L, Olde Loohuis LM, Melle I, Morgan C, Morris DW, Murray RM, Nyman H, Ophoff RA; GROUP Investigators, van Os J; EUGEI WP2 Group; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Petryshen TL, Quattrone D, Rietschel M, Rujescu D, Rutten BPF, Streit F, Strohmaier J, Sullivan PF, Sundet K, Wagner M, Escott-Price V, Owen MJ, Donohoe G, O'Donovan MC, Walters JTR.

Schizophr Bull. 2019 Jun 17. pii: sbz061. doi: 10.1093/schbul/sbz061. [Epub ahead of print]

PMID:
31206164
13.

Correction: Amphetamine Sensitization Alters Reward Processing in the Human Striatum and Amygdala.

O'Daly OG, Joyce D, Tracy DK, Azim A, Stephan KE, Murray RM, Shergill SS.

PLoS One. 2019 Jun 12;14(6):e0218478. doi: 10.1371/journal.pone.0218478. eCollection 2019.

14.

Tobacco smoking and nicotine dependence in first episode and established psychosis.

Lally J, Spaducci G, Gardner-Sood P, Atakan Z, Greenwood K, Di Forti M, Ismail K, Murphy KC, Smith S, McNeill A, Murray RM, Gaughran F.

Asian J Psychiatr. 2019 May 4;43:125-131. doi: 10.1016/j.ajp.2019.05.002. [Epub ahead of print]

PMID:
31132542
15.

High-potency cannabis and incident psychosis: correcting the causal assumption - Authors' reply.

Di Forti M, Morgan C, Selten JP, Lynskey M, Murray RM.

Lancet Psychiatry. 2019 Jun;6(6):466-467. doi: 10.1016/S2215-0366(19)30176-2. No abstract available.

PMID:
31122474
16.

Differential gene expression analysis in blood of first episode psychosis patients.

Leirer DJ, Iyegbe CO, Di Forti M, Patel H, Carra E, Fraietta S, Colizzi M, Mondelli V, Quattrone D, Lally J, Ajnakina O, Lee SH, Curtis CJ, Breen G, Pariante C, Aitchison K, Dazzan P, Murray RM, Dobson RJB, Newhouse SJ.

Schizophr Res. 2019 Jul;209:88-97. doi: 10.1016/j.schres.2019.05.011. Epub 2019 May 19.

17.

The Psychiatric Risk Gene NT5C2 Regulates Adenosine Monophosphate-Activated Protein Kinase Signaling and Protein Translation in Human Neural Progenitor Cells.

Duarte RRR, Bachtel ND, Côtel MC, Lee SH, Selvackadunco S, Watson IA, Hovsepian GA, Troakes C, Breen GD, Nixon DF, Murray RM, Bray NJ, Eleftherianos I, Vernon AC, Powell TR, Srivastava DP.

Biol Psychiatry. 2019 Jul 15;86(2):120-130. doi: 10.1016/j.biopsych.2019.03.977. Epub 2019 Mar 30.

18.

Hospitalisation and length of hospital stay following first-episode psychosis: systematic review and meta-analysis of longitudinal studies.

Ajnakina O, Stubbs B, Francis E, Gaughran F, David AS, Murray RM, Lally J.

Psychol Med. 2019 May 6:1-11. doi: 10.1017/S0033291719000904. [Epub ahead of print]

PMID:
31057129
19.

Verbal Fluency Is Affected by Altered Brain Lateralization in Adults Who Were Born Very Preterm.

Tseng CJ, Froudist-Walsh S, Kroll J, Karolis V, Brittain PJ, Palamin N, Clifton H, Counsell SJ, Williams SCR, Murray RM, Nosarti C.

eNeuro. 2019 Apr 15;6(2). pii: ENEURO.0274-18.2018. doi: 10.1523/ENEURO.0274-18.2018. eCollection 2019 Mar-Apr.

20.

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.

Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19.

21.

Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence.

Vieira S, Gong QY, Pinaya WHL, Scarpazza C, Tognin S, Crespo-Facorro B, Tordesillas-Gutierrez D, Ortiz-García V, Setien-Suero E, Scheepers FE, Van Haren NEM, Marques TR, Murray RM, David A, Dazzan P, McGuire P, Mechelli A.

Schizophr Bull. 2019 Feb 27. pii: sby189. doi: 10.1093/schbul/sby189. [Epub ahead of print]

PMID:
30809667
22.

Construction of Incoherent Feedforward Loop Circuits in a Cell-Free System and in Cells.

Guo S, Murray RM.

ACS Synth Biol. 2019 Mar 15;8(3):606-610. doi: 10.1021/acssynbio.8b00493. Epub 2019 Mar 6.

PMID:
30790525
23.

Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study.

Luo Q, Chen Q, Wang W, Desrivières S, Quinlan EB, Jia T, Macare C, Robert GH, Cui J, Guedj M, Palaniyappan L, Kherif F, Banaschewski T, Bokde ALW, Büchel C, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Artiges E, Paillère-Martinot ML, Nees F, Orfanos DP, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Callicott JH, Mattay VS, Pausova Z, Dartigues JF, Tzourio C, Crivello F, Berman KF, Li F, Paus T, Weinberger DR, Murray RM, Schumann G, Feng J; IMAGEN consortium.

JAMA Psychiatry. 2019 Apr 1;76(4):435-445. doi: 10.1001/jamapsychiatry.2018.4126.

24.

'At risk mental state' clinics for psychosis - an idea whose time has come - and gone!

Ajnakina O, David AS, Murray RM.

Psychol Med. 2018 Dec 26:1-6. doi: 10.1017/S0033291718003859. [Epub ahead of print]

PMID:
30585562
25.

The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial.

Lally J, Watkins R, Nash S, Shetty H, Gardner-Sood P, Smith S, Murray RM, Gaughran F.

Front Psychiatry. 2018 Dec 4;9:654. doi: 10.3389/fpsyt.2018.00654. eCollection 2018.

26.

Assessing cross-national invariance of the Community Assessment of Psychic Experiences (CAPE).

Pignon B, Peyre H, Ferchiou A, van Os J, Rutten BPF, Murray RM, Morgan C, Leboyer M, Schürhoff F, Szöke A; EU-GEI WP2 Group Author.

Psychol Med. 2018 Dec 5:1-8. doi: 10.1017/S0033291718003574. [Epub ahead of print]

PMID:
30514407
27.

Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study.

Rodriguez V, Ajnakina O, Stilo SA, Mondelli V, Marques TR, Trotta A, Quattrone D, Gardner-Sood P, Colizzi M, Wiffen BD, Dazzan P, Di Forti M, Falcone MA, David AS, Murray RM.

Psychol Med. 2018 Nov 5:1-11. doi: 10.1017/S0033291718003197. [Epub ahead of print]

PMID:
30392491
28.

Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study.

Kravariti E, Demjaha A, Zanelli J, Ibrahim F, Wise C, MacCabe JH, Reichenberg A, Pilecka I, Morgan K, Fearon P, Morgan C, Doody GA, Donoghue K, Jones PB, Kaçar AŞ, Dazzan P, Lappin J, Murray RM.

Psychol Med. 2018 Oct 23:1-11. doi: 10.1017/S0033291718002957. [Epub ahead of print]

PMID:
30348234
29.

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, Jongsma HE, Tripoli G, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Lasalvia A, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP; EU-GEI WP2 Group, Jones PB, Kirkbride JB, Richards AL, O'Donovan MC, Sham PC, Vassos E, Rutten BP, van Os J, Morgan C, Lewis CM, Murray RM, Reininghaus U.

Psychol Med. 2019 Jun;49(8):1378-1391. doi: 10.1017/S0033291718002131. Epub 2018 Oct 4.

30.

Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression.

Lopez-Morinigo JD, Di Forti M, Ajnakina O, Wiffen BD, Morgan K, Doody GA, Jones PB, Ayesa-Arriola R, Canal-Rivero M, Crespo-Facorro B, Murray RM, Dazzan P, Morgan C, Dutta R, David AS.

Schizophr Res. 2019 Feb;204:80-89. doi: 10.1016/j.schres.2018.09.016. Epub 2018 Sep 22.

PMID:
30253893
31.

Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis.

Nettis MA, Pergola G, Kolliakou A, O'Connor J, Bonaccorso S, David A, Gaughran F, Di Forti M, Murray RM, Marques TR, Blasi G, Bertolino A, Pariante CM, Dazzan P, Mondelli V.

Psychoneuroendocrinology. 2019 Jan;99:145-153. doi: 10.1016/j.psyneuen.2018.09.005. Epub 2018 Sep 8.

PMID:
30243054
32.

Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort study.

Lally J, Ajnakina O, Singh N, Gardner-Sood P, Stubbs B, Stringer D, Di Forti M, David AS, Smith S, Murray RM, Howes OD, Gaughran F.

Schizophr Res. 2019 Feb;204:381-388. doi: 10.1016/j.schres.2018.08.011. Epub 2018 Aug 25.

PMID:
30154029
33.

Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients.

Ajnakina O, Trotta A, Forti MD, Stilo SA, Kolliakou A, Gardner-Sood P, Lopez-Morinigo J, Gaughran F, David AS, Dazzan P, Pariante C, Mondelli V, Murray RM, Fisher HL.

Psychiatry Res. 2018 Nov;269:199-206. doi: 10.1016/j.psychres.2018.08.054. Epub 2018 Aug 17.

PMID:
30153597
34.

Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis.

Cullen AE, Holmes S, Pollak TA, Blackman G, Joyce DW, Kempton MJ, Murray RM, McGuire P, Mondelli V.

Biol Psychiatry. 2019 Jan 1;85(1):35-48. doi: 10.1016/j.biopsych.2018.06.016. Epub 2018 Jun 28.

35.

Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.

Calafato MS, Thygesen JH, Ranlund S, Zartaloudi E, Cahn W, Crespo-Facorro B, Díez-Revuelta Á, Di Forti M; Genetic Risk and Outcome of Psychosis (GROUP) consortium, Hall MH, Iyegbe C, Jablensky A, Kahn R, Kalaydjieva L, Kravariti E, Lin K, McDonald C, McIntosh AM, McQuillin A, Picchioni M, Rujescu D, Shaikh M, Toulopoulou T, Os JV, Vassos E, Walshe M, Powell J, Lewis CM, Murray RM, Bramon E.

Br J Psychiatry. 2018 Sep;213(3):535-541. doi: 10.1192/bjp.2018.89.

36.

On-chip membrane protein cell-free expression enables development of a direct binding assay: A curious case of potassium channel KcsA-Kv1.3.

Vaish A, Guo S, Murray RM, Grandsard PJ, Chen Q.

Anal Biochem. 2018 Sep 1;556:70-77. doi: 10.1016/j.ab.2018.06.018. Epub 2018 Jun 21.

PMID:
29936096
37.

Is the grass greener for those at risk of psychosis?

Murray RM.

Schizophr Res. 2018 Nov;201:35-36. doi: 10.1016/j.schres.2018.04.041. Epub 2018 Jun 18. No abstract available.

PMID:
29914789
38.

Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics.

Murray RM, Di Forti M.

World Psychiatry. 2018 Jun;17(2):161-162. doi: 10.1002/wps.20517. No abstract available.

39.

Cortical thickness correlates of minor neurological signs in patients with first episode psychosis.

Ciufolini S, Ponteduro MF, Reis-Marques T, Taylor H, Mondelli V, Pariante CM, Bonaccorso S, Chan R, Simmons A, David A, Di Forti M, Murray RM, Dazzan P.

Schizophr Res. 2018 Oct;200:104-111. doi: 10.1016/j.schres.2018.05.005. Epub 2018 May 18.

PMID:
29785932
40.

Cortisol awakening response is decreased in patients with first-episode psychosis and increased in healthy controls with a history of severe childhood abuse.

Ciufolini S, Gayer-Anderson C, Fisher HL, Marques TR, Taylor H, Di Forti M, Zunszain P, Morgan C, Murray RM, Pariante CM, Dazzan P, Mondelli V.

Schizophr Res. 2019 Mar;205:38-44. doi: 10.1016/j.schres.2018.05.002. Epub 2018 May 24.

PMID:
29776641
41.

Single Day Construction of Multigene Circuits with 3G Assembly.

Halleran AD, Swaminathan A, Murray RM.

ACS Synth Biol. 2018 May 18;7(5):1477-1480. doi: 10.1021/acssynbio.8b00060. Epub 2018 May 7.

PMID:
29715010
42.

Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis.

Trotta A, Iyegbe C, Yiend J, Dazzan P, David AS, Pariante C, Mondelli V, Colizzi M, Murray RM, Di Forti M, Fisher HL.

Schizophr Res. 2019 Mar;205:51-57. doi: 10.1016/j.schres.2018.04.010. Epub 2018 Apr 10.

PMID:
29653893
43.

The antipsychotic landscape: dopamine and beyond.

Morrison PD, Murray RM.

Ther Adv Psychopharmacol. 2018 Apr;8(4):127-135. doi: 10.1177/2045125317752915. Epub 2018 Jan 23. Review.

44.

Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.

Lappin JM, Heslin M, Lomas B, Jones PB, Doody GA, Reininghaus UA, Croudace T, Craig T, Fearon P, Murray RM, Dazzan P, Morgan C.

Schizophr Res. 2018 Sep;199:341-345. doi: 10.1016/j.schres.2018.03.014. Epub 2018 Mar 20.

PMID:
29571751
45.

Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders.

Scheffler F, Kilian S, Chiliza B, Asmal L, Phahladira L, du Plessis S, Kidd M, Murray RM, Di Forti M, Seedat S, Emsley R.

Schizophr Res. 2018 Sep;199:90-95. doi: 10.1016/j.schres.2018.02.050. Epub 2018 Mar 6.

PMID:
29519756
46.

Validation of an algorithm-based definition of treatment resistance in patients with schizophrenia.

Ajnakina O, Horsdal HT, Lally J, MacCabe JH, Murray RM, Gasse C, Wimberley T.

Schizophr Res. 2018 Jul;197:294-297. doi: 10.1016/j.schres.2018.02.017. Epub 2018 Feb 19.

PMID:
29472163
47.

What causes psychosis? An umbrella review of risk and protective factors.

Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, Yenn Thoo H, Oliver D, Davies C, Morgan C, McGuire P, Murray RM, Fusar-Poli P.

World Psychiatry. 2018 Feb;17(1):49-66. doi: 10.1002/wps.20490.

48.

A dimensional approach to assessing psychiatric risk in adults born very preterm.

Kroll J, Froudist-Walsh S, Brittain PJ, Tseng CJ, Karolis V, Murray RM, Nosarti C.

Psychol Med. 2018 Jul;48(10):1738-1744. doi: 10.1017/S0033291717003804. Epub 2018 Jan 19.

PMID:
29350124
49.

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study.

Jongsma HE, Gayer-Anderson C, Lasalvia A, Quattrone D, Mulè A, Szöke A, Selten JP, Turner C, Arango C, Tarricone I, Berardi D, Tortelli A, Llorca PM, de Haan L, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Velthorst E, Murray RM, Rutten BP, Jones PB, van Os J, Morgan C, Kirkbride JB; European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group.

JAMA Psychiatry. 2018 Jan 1;75(1):36-46. doi: 10.1001/jamapsychiatry.2017.3554.

50.

The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life.

Froudist-Walsh S, Bloomfield MA, Veronese M, Kroll J, Karolis VR, Jauhar S, Bonoldi I, McGuire PK, Kapur S, Murray RM, Nosarti C, Howes O.

Elife. 2017 Nov 28;6. pii: e29088. doi: 10.7554/eLife.29088.

Supplemental Content

Loading ...
Support Center